Long-term pharmacokinetics of the metabolites of everolimus and cyclosporine in renal transplant recipients

Transplant Proc. 2002 Sep;34(6):2233-4. doi: 10.1016/s0041-1345(02)03217-7.

Authors

G Kirchner¹, L Mueller, M Winkler, M Loss, F Roechte, M Deters, U Christians, V Kaever, J Klempnauer, K Sewing, M Manns

Affiliation

¹ Department of Gastroenterology and Hepatology, Medical School of Hannover, Hannover, Germany. Kirchner.Gabriele@MH-Hannover.de

PMID: 12270379
DOI: 10.1016/s0041-1345(02)03217-7

No abstract available

Publication types

Clinical Trial
Clinical Trial, Phase I

MeSH terms

Biotransformation
Cyclosporine / pharmacokinetics*
Drug Therapy, Combination
Everolimus
Humans
Immunosuppressive Agents / adverse effects
Immunosuppressive Agents / pharmacokinetics
Kidney Transplantation / immunology*
Metabolic Clearance Rate
Sirolimus / adverse effects
Sirolimus / analogs & derivatives
Sirolimus / pharmacokinetics*

Substances

Immunosuppressive Agents
Cyclosporine
Everolimus
Sirolimus